AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-33.97%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$51M
AUM Growth
+$51M
(-46%)
Cap. Flow
-$10M
Cap. Flow
% of AUM
-19.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$3.08M |
Top Sells
| 1 |
Akebia Therapeutics
AKBA
|
$7.61M |
| 2 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$5.51M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Annexon
ANNX
$226M
| $36.3M | 71.13% |
7,406,024
| – | – |
|
|
2
Akebia Therapeutics
AKBA
$833M
| $5.86M | 11.49% |
5,747,906
-7,457,213
| -56% | -$7.61M |
|
3
American Well
AMWL
$111M
| $3.4M | 6.67% |
10,475,717
| – | – |
|
|
VRNA
4
Verona Pharma
VRNA
$9.16B
| $3.08M | 6.04% |
+213,000
| New | +$3.08M |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $2.38M | 4.67% |
1,630,830
| – | – |
|
|
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| – | – |
-830,466
| Closed | -$5.51M |
|